In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.
The brain and vagus nerve play a key role in exacerbating tissue damage after a heart attack, but there are ways to block it.
Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...
A Tokyo-based startup said transplants of cardiac muscle cells that it engineered from induced pluripotent stem (iPS) cells ...
When the heart's muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood ...
Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...
More than half of people with advanced kidney disease develop cardiovascular problems. A new study finds that diseased kidneys release tiny particles that are toxic to the heart.
SGMC Health is expanding its advanced cardiac imaging capabilities with the introduction of Positron Emission Tomography (PET) cardiac stress testing, offering patients faster, more accurate ...
John Barrass, 78, is successfully treated at Sheffield's Northern General Hospital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results